Therefore, we explored how effective pharmacological intervention would be for NASH microtissues with high NPC numbers supplemented with TGFβ and exposed them to varying concentrations of OCA and ELF QD as previously described (Supp. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatohepatitis.